Contracts › 75N93026F00002
75N93026F00002: Screening Candidate Countermeasures for Viral Hemorrhagic Fever Using Liver-Based Organ-On-A-Chip Microphysiological Systems (MPS) in High-Level Containment
Awarded to University of Texas Medical Branch at Galveston by National Institutes of Health (NIH).
$1.4Mobligated
$6.3Mpotential value
26 July 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93026F00002 |
|---|---|
| Vehicle | 75N93024D00042 |
| Awardee | University of Texas Medical Branch at Galveston |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | TX |
| Period of performance | 27 July 2026 to 26 July 2027 |
| Potential end | 26 July 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record